Methylprednisolone

Methylprednisolone has been studied in 11 papers since 2016: 1 trial and 2 observational studies in people, 2 in animals, 2 reviews; 5 in the past year. It is an approved medicine. The newest paper, Nov 17, 2026: “Painful Non‐Diabetic Lumbosacral Radiculoplexus Neuropathy Following Tirzepatide Exposure: A Case Report”.

InterventionApproved 1957

11 papers study it6 more mention it9 findingsUpdated

PubChemChEBIMeSH

1 new paper in 30 daysSee all 17 papers on methylprednisolone

At a glance

The findings reach people, from one lab or study. 3 independent labs in 3 countries; 413 trials, 2 about aging, 130 with no results posted.

“methylprednisolone greatly reduced the incidence of delirium at 72 hours following surgery (9 [10.7%] vs 20 [23.8%], p = .03, OR = 2.22 [95% CI 1.05-4.59])”
The Effect of Preoperative Methylprednisolone on Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: A Randomized, Double-Blind, Placebo-Controlled TrialThe journals of gerontology. Series A, Biological sciences and medical sciences2021doi:10.1093/gerona/glab248

None of its findings points the other way.

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 3 independent labs in 3 countries
  • 413 trials, 2 about aging, 130 with no results posted
  • Funders: Medical Science and Technology Project of Zhejiang Province and 1 more
  • Human trial1
  • Humans2
  • Animals2

Studies in people

1 study gave methylprednisolone to people and measured what changed.

What changedDesignPeopleSource

down: Lowers the risk of postoperative delirium9 (10.7%) vs 20 (23.8%)

no change: Has no effect on delirium severityp = .14

down: Decreases SYNDECAN-1p < .05 and p < .01

Randomized trialsingle preoperative dose168 people65-80 yearsOlder adults; postoperative delirium following laparoscopic gastrointestinal surgeryThe journals of gerontology. Series A, Biological sciences and medical sciences, Aug 24, 2021

What did studies of methylprednisolone find?

5

Studies of methylprednisolone measured 5 outcomes, among them seizures, BDNF and SYNDECAN-1.

Seizures

downin humans1

1 study
  1. Methylprednisolone is linked with lower seizures in tirzepatide-associated limbic encephalitis with status epilepticus (complete control within 24 h).

    “High-dose intravenous methylprednisolone (2 g/day × 3 days, then tapered) granted complete control of seizures within 24 h.”

    Humansin tirzepatide-associated limbic encephalitis with status epilepticus2 g/day × 3 days, then tapered3 days, then taperedmalesn = 1

    Probable tirzepatide-associated limbic encephalitis with status epilepticus in a patient with extreme obesity: a case report

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

BDNF

upin humans1

1 study
  1. Methylprednisolone increases BDNF in humans (older patients undergoing gastrointestinal surgery) (p < .01).

    “while the level of BDNF in Group M was higher than that in Group C (p < .01).”

    Human trialolder patients undergoing gastrointestinal surgerycirculating2 mg/kgsingle preoperative dosen = 168

    The Effect of Preoperative Methylprednisolone on Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on BDNF

SYNDECAN-1

downin humans1

1 study
  1. Methylprednisolone decreases SYNDECAN-1 in humans (older patients undergoing gastrointestinal surgery) (p < .05 and p < .01).

    “The levels of heparan sulfate, syndecan-1, and TNF-α in Group M were lower than that in Group C (p < .05 and p < .01)”

    Human trialolder patients undergoing gastrointestinal surgerycirculating2 mg/kgsingle preoperative dosen = 168

    The Effect of Preoperative Methylprednisolone on Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on SYNDECAN-1

Delirium severity

no changein humans1

1 study
  1. Methylprednisolone showed no clear effect on delirium severity in humans (older patients undergoing gastrointestinal surgery) (p = .14).

    “No between-group difference was found in the cumulative CAM-S score (p = .14).”

    Human trialolder patients undergoing gastrointestinal surgery2 mg/kgsingle preoperative dosen = 168

    The Effect of Preoperative Methylprednisolone on Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

    The journals of gerontology. Series A, Biological sciences and medical sciences

Taurine

upin reviews1

1 study
  1. Methylprednisolone increases taurine in spinal cord injury therapy.

    “Higher level of taurine has been also recorded in SCI therapy using, known clinical agent methyl prednisolone (MP)”

    Reviewin spinal cord injury therapy

    Role of taurine in spinal cord injury

    Current neurovascular research

More on Taurine

What is methylprednisolone linked with?

4

Studies link methylprednisolone with 4 measures, among them KL, CYP24A1 and TRPV5.

KL

mixedin O. aries1

1 study
  1. Methylprednisolone is associated with KL in O. aries after adjustment for repeated measures.

    “Differences in klotho expression were most marked after adjustment for repeated measures (p = 0.1).”

    Animalsafter adjustment for repeated measureskidneyfemales

    Expression of Renal Vitamin D and Phosphatonin-Related Genes in a Sheep Model of Osteoporosis

    Animals : an open access journal from MDPI

More on KL

CYP24A1

mixedin O. aries1

1 study
  1. Methylprednisolone is associated with CYP24A1 in ovariectomized sheep treated for 2 months and euthanized at 5 months.

    “Ovariectomized sheep treated with glucocorticoids for 2 months followed by euthanasia at 5 months showed significant differences in TRPV5, CYP24A1 and klotho gene expression compared to other groups.”

    Animalsin ovariectomized sheep treated for 2 months and euthanized at 5 monthskidney2 months of treatment, euthanized at 5 monthsfemales

    Expression of Renal Vitamin D and Phosphatonin-Related Genes in a Sheep Model of Osteoporosis

    Animals : an open access journal from MDPI

More on CYP24A1

TRPV5

mixedin O. aries1

1 study
  1. Methylprednisolone is associated with TRPV5 in ovariectomized sheep treated for 2 months and euthanized at 5 months.

    “Ovariectomized sheep treated with glucocorticoids for 2 months followed by euthanasia at 5 months showed significant differences in TRPV5, CYP24A1 and klotho gene expression compared to other groups.”

    Animalsin ovariectomized sheep treated for 2 months and euthanized at 5 monthskidney2 months of treatment, euthanized at 5 monthsfemales

    Expression of Renal Vitamin D and Phosphatonin-Related Genes in a Sheep Model of Osteoporosis

    Animals : an open access journal from MDPI

More on TRPV5

Postoperative delirium

downin humans1

1 study
  1. Methylprednisolone lowers the risk of postoperative delirium in humans (postoperative delirium following laparoscopic gastrointestinal surgery) (9 (10.7%) vs 20 (23.8%)).

    “methylprednisolone greatly reduced the incidence of delirium at 72 hours following surgery (9 [10.7%] vs 20 [23.8%], p = .03, OR = 2.22 [95% CI 1.05-4.59])”

    Human trialpostoperative delirium following laparoscopic gastrointestinal surgerycirculating2 mg/kgsingle preoperative dosen = 168

    The Effect of Preoperative Methylprednisolone on Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Postoperative delirium

Has methylprednisolone been tested in people?

2 of 413 about aging

Yes: 1 trial and 2 observational studies in people have been published, and 413 trials are registered.

Approved

  • FDA Medrol

    Oct 24, 1957Arthritis, Psoriatic, Arthritis, Rheumatoid, Bursitis, Dermatomyositis, Erythema Multiforme, Lupus Erythematosus, Systemic, Mycosis Fungoides, Osteoarthritis, Spondylitis, Ankylosing, Tenosynovitis, psoriasis, pemphigus, dermatitis, juvenile rheumatoid arthritis, acute gouty arthritis, Hypercalcemia, synovitis, post-traumatic osteoarthritis, seborrheic dermatitis, adrenocortical insufficiency, thyroiditis, congenital adrenal hyperplasia, perennial allergic rhinitis, drug hypersensitivity, Colitis, Ulcerative, Multiple Sclerosis, Nephrotic Syndrome, Proteinuria, Thrombocytopenia, pulmonary tuberculosis, atopic dermatitis, sarcoidosis, lupus erythematosus, aspiration pneumonitis, hemolytic anemia, Lymphomas, acute leukemia, drug hypersensitivity reactions, idiopathic thrombocytopenic purpura, tuberculous meningitis, contact dermatitis, bronchial asthma, berylliosis

  • FDA Solu-Medrol

    May 18, 1959Asthma, Colitis, Ulcerative, Erythema Multiforme, Mycosis Fungoides, atopic dermatitis, pemphigus, dermatitis, Hypercalcemia, hemolytic anemia, adrenocortical insufficiency, drug hypersensitivity reactions, idiopathic thrombocytopenic purpura, contact dermatitis, thyroiditis, congenital adrenal hyperplasia, Arthritis, Psoriatic, Arthritis, Rheumatoid, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Proteinuria, Spondylitis, Ankylosing, Thrombocytopenia, Uveitis, pulmonary tuberculosis, sarcoidosis, polymyositis, juvenile rheumatoid arthritis, lupus erythematosus, acute gouty arthritis, Lymphomas, tuberculous meningitis, idiopathic nephrotic syndrome, berylliosis, ocular inflammatory conditions, temporal arteritis

  • FDA Depo-Medrol

    May 27, 1959Asthma, Colitis, Ulcerative, Erythema Multiforme, Mycosis Fungoides, Thrombocytopenia, atopic dermatitis, pemphigus, dermatitis, Hypercalcemia, hemolytic anemia, adrenocortical insufficiency, drug hypersensitivity reactions, contact dermatitis, thyroiditis, congenital adrenal hyperplasia, Alopecia Areata, Arthritis, Psoriatic, Arthritis, Rheumatoid, Bursitis, Dermatomyositis, Lupus Erythematosus, Systemic, Osteoarthritis, Proteinuria, Spondylitis, Ankylosing, Tenosynovitis, Uveitis, pulmonary tuberculosis, sarcoidosis, polymyositis, juvenile rheumatoid arthritis, lupus erythematosus, acute gouty arthritis, synovitis, lichen planus, cerebral edema, Lymphomas, lichen simplex chronicus, tuberculous meningitis, granuloma annulare, idiopathic nephrotic syndrome, discoid lupus erythematosus, berylliosis, ocular inflammatory conditions, temporal arteritis

  • FDA Medrol Acetate

    Jun 21, 1960Discontinued

  • FDA Medrol

    Dec 21, 1977Discontinued

Repurposing

40 of 203

Every condition in trials

  • Adverse effects

    Phase 4Completed2 trials

  • Cluster Headache

    Phase 4Completed2 trials

  • Glucocorticoids

    Phase 4Status unknown2 trials

  • Advanced follicular lymphoma

    Phase 4Results posted1 trial

  • Cardiopulmonary bypass

    Phase 4Status unknown1 trial

  • Immune reconstitution inflammatory syndrome

    Phase 4Terminated1 trial

40 of 60

Stopped

  • NCT02921555TerminatedUlcerative colitis

    slow recruitment rate

  • NCT03704584TerminatedTenosynovitis

    Enrollment and study activities were initially suspended due to COVID-19. The investigator has also left Emory and the study will not resume.

  • NCT01281748TerminatedChronic obstructive pulmonary disease

    Low rate of enrollment

  • NCT01742338TerminatedChronic obstructive pulmonary disease

    Lack of research staff to recruit participants

  • NCT03898154TerminatedWrist fracture

    Study discontinued due to departure of research staff and changes in institutional priorities. Study failed to meet enrollment goals of 200 total participants (n=100/study arm)

  • NCT04393207TerminatedAcute pain

    Slow/low recruitment, unable to recruit

All 34

Who is developing methylprednisolone?

3 companies: Astellas Pharma, Incyte and Oncotherapeutics.

Companies
  • Astellas PharmaPhase 4kidney transplantation
  • IncytePhase 1/2acute graft versus host disease
  • OncotherapeuticsPhase 1multiple myeloma in relapse, refractory multiple myeloma

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 2Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 16 papers in 12 months

See all 17 papers on methylprednisolone